| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/08/2013 | US8349322 Stable and soluble antibodies inhibiting VEGF |
| 01/08/2013 | US8349321 Immunoglobulin formulation and method of preparation thereof |
| 01/08/2013 | CA2629643C Inhibitory and non-inhibitory antigen binding polypeptides against human p450 enzymes |
| 01/08/2013 | CA2620343C Process for preparing antibody maytansinoid conjugates |
| 01/08/2013 | CA2578141C Production of polypeptides |
| 01/08/2013 | CA2574881C Antibodies to dkk-1 |
| 01/08/2013 | CA2572671C Cytoxan antibodies and immunoassay |
| 01/08/2013 | CA2543982C Antibodies that bind interleukin-4 receptor |
| 01/08/2013 | CA2531118C Multivalent carriers of bi-specific antibodies |
| 01/08/2013 | CA2489004C Agonistic binding molecules to the human ox40 receptor |
| 01/08/2013 | CA2470262C Glycoconjugates and their use as potential vaccines against infection by shigella flexneri |
| 01/08/2013 | CA2457541C Methods for the identification of polypeptide antigens associated with disorders involving aberrant cell proliferation and compositions useful for the treatment of such disorders |
| 01/08/2013 | CA2454361C Humanized antibodies |
| 01/08/2013 | CA2441577C Therapeutic agents for inflammatory bowel diseases |
| 01/08/2013 | CA2390095C Method and system to remove cytokine inhibitor in patients |
| 01/08/2013 | CA2341777C Neutral amino acid transporter and gene thereof |
| 01/08/2013 | CA2317727C Multipurpose antibody derivatives |
| 01/08/2013 | CA2305681C Apoptosis-related compounds and their use |
| 01/08/2013 | CA2286090C Forms of prostate specific antigen and methods for their detection |
| 01/08/2013 | CA2267667C Bacillus thuringiensis cryet29 compositions toxic to coleopteran insects and ctenocephalides spp |
| 01/08/2013 | CA2223608C Vaccine for porcine reproductive and respiratory syndrome virus |
| 01/03/2013 | WO2013003680A1 Anti-c-met antibody formulations |
| 01/03/2013 | WO2013003652A1 Multispecific stacked variable domain binding proteins |
| 01/03/2013 | WO2013003625A2 Antibodies |
| 01/03/2013 | WO2013003555A1 Using sortases to install click chemistry handles for protein ligation |
| 01/03/2013 | WO2013002362A1 Heterodimerized polypeptide |
| 01/03/2013 | WO2013002086A1 Receptor gene for peptide cancer antigen-specific t cell |
| 01/03/2013 | WO2013001819A1 SOLUBLE INTEGRIN α4 MUTANT |
| 01/03/2013 | WO2013001517A1 Polypeptides and uses thereof for treatment of autoimmune disorders and infection |
| 01/03/2013 | WO2013001065A1 Antibodies against prostate-specific stem cell antigen and use thereof |
| 01/03/2013 | WO2013000568A1 Method of obtaining a binder to prepro-vasopressin or fragments thereof |
| 01/03/2013 | WO2013000471A1 Therapeutic targeting of ficolin-3 |
| 01/03/2013 | WO2013000064A1 Alternative splicing modulators and splice variants and their use in the control and detection of pluripotency and differentiation |
| 01/03/2013 | WO2012170607A3 Use of pcsk9 antagonists |
| 01/03/2013 | WO2012154311A3 Focused evolution of hiv-1 neutralizing antibodies revealed by crystal structures and deep sequencing |
| 01/03/2013 | WO2012143524A3 Bispecific antibodies against her2 and cd3 |
| 01/03/2013 | WO2012135284A3 Targeted protein silencing using chimeras between antibodies and ubiquitination enzymes |
| 01/03/2013 | WO2012128502A9 Composition for promoting vasculogenesis comprising pauf |
| 01/03/2013 | WO2012103165A3 Anti-kit antibodies and uses thereof |
| 01/03/2013 | WO2012071372A3 Human antibodies to the glucagon receptor |
| 01/03/2013 | US20130007922 Method for modifying plant morphology, biochemistry and physiology |
| 01/03/2013 | US20130007919 Intein-modified enzymes, their production and industrial applications |
| 01/03/2013 | US20130006092 Magnetic Nanoparticle Compositions and Methods of Use Thereof |
| 01/03/2013 | US20130005949 Antibodies against human csf-1r and uses thereof |
| 01/03/2013 | US20130005659 Il-17 binding compounds and medical uses thereof |
| 01/03/2013 | US20130005610 Toxicity-associated genes, genetic variants, and use thereof |
| 01/03/2013 | US20130004995 Beta 1,3-n-acetyl-d-galactosamine transferase protein, nucleic acid encoding the same and method of examining canceration using the same |
| 01/03/2013 | US20130004976 Human insulin assay and assay reagent |
| 01/03/2013 | US20130004971 CYSTATIN C, beta2 MICROGLOBULIN, alpha1 MICROGLOBULIN AND GENES FOR SAME, ANTIBODY, AND KIT AND METHOD FOR DIAGNOSIS OF FELINE NEPHROPATHY |
| 01/03/2013 | US20130004963 Tyrosine, serine and threonine phosphorylation sites |
| 01/03/2013 | US20130004955 Ovary Tumor Markers and Methods of Use Thereof |
| 01/03/2013 | US20130004944 H5 Subtype-Specific Binding Proteins Useful for H5 Avian Influenza Diagnosis and Surveillance |
| 01/03/2013 | US20130004943 H5 Subtype-Specific Binding Proteins Useful for H5 Avian Influenza Diagnosis and Surveillance |
| 01/03/2013 | US20130004524 Conjugated Proteins |
| 01/03/2013 | US20130004523 Therapeutic compositions and methods for delivery of active agents cleavably linked to nanoparticles |
| 01/03/2013 | US20130004514 Therapeutic antibodies |
| 01/03/2013 | US20130004513 Agents for treating disease |
| 01/03/2013 | US20130004510 Vaccine |
| 01/03/2013 | US20130004509 BRAF Mutations Conferring Resistance to BRAF Inhibitors |
| 01/03/2013 | US20130004508 Engineered anti-tslp antibody |
| 01/03/2013 | US20130004507 METHODS OF ADMINISTERING ANTI-TNFalpha ANTIBODIES |
| 01/03/2013 | US20130004505 Human monoclonal antibodies derived from human b cells and having neutralizing activity against influenza a viruses |
| 01/03/2013 | US20130004504 Method of modulating phenylalanine hydroxylase structure and function |
| 01/03/2013 | US20130004502 Influenza targets |
| 01/03/2013 | US20130004501 Human il-23 antigen binding proteins |
| 01/03/2013 | US20130004500 Antibody against serotype a lipopolysaccharide of pseudomonas aeruginosa |
| 01/03/2013 | US20130004499 Antibody against serotype e lipopolysaccharide of pseudomonas aeruginosa |
| 01/03/2013 | US20130004497 Monoclonal antibodies specific to hemagglutinin and neuraminidase from influenza virus h5-subtype or n1-subtype and uses thereof |
| 01/03/2013 | US20130004496 Monoclonal antibodies specific to hemagglutinin and neuraminidase from influenza virus h5-subtype or n1-subtype and uses thereof |
| 01/03/2013 | US20130004495 Anti-ngf antibodies for the treatment of various disorders |
| 01/03/2013 | US20130004494 Inhibition of P21 and Use Thereof for Inducing Tissue Regeneration |
| 01/03/2013 | US20130004491 Antibodies Against Phosphorylcholine In Combination Therapy with Biologic Agents |
| 01/03/2013 | US20130004490 Delivery of transthyretin across the blood-brain barrier as a treatment for alzheimer's disease |
| 01/03/2013 | US20130004485 Humanized and chimeric anti-properdin antibodies |
| 01/03/2013 | US20130004432 Monoclonal antibodies that bind b7h6 and uses thereof |
| 01/03/2013 | US20130004423 Polyazamacrocyclic compound, and a production method and a biomedical use therefor |
| 01/03/2013 | US20130004416 Dual Variable Domain Immunoglobulin and Uses Thereof |
| 01/03/2013 | DE102011118022A1 Antikörper gegen das Prostata-spezifische Stammzellenantigen und dessen Verwendung Antibodies to the prostate specific antigen stem cells and the use thereof |
| 01/03/2013 | CA2840577A1 Soluble integrin .alpha.4 mutant |
| 01/03/2013 | CA2840537A1 Antibodies |
| 01/03/2013 | CA2840409A1 Using sortases to install click chemistry handles for protein ligation |
| 01/03/2013 | CA2839683A1 Therapeutic targeting of ficolin-3 |
| 01/03/2013 | CA2839663A1 Receptor gene for peptide cancer antigen-specific t cell |
| 01/03/2013 | CA2839622A1 Wap domain fusion polypeptides and methods of use thereof |
| 01/03/2013 | CA2839619A1 Serpin fusion polypeptides and methods of use thereof |
| 01/03/2013 | CA2839539A1 Heterodimerized polypeptide |
| 01/03/2013 | CA2839462A1 Inhibitors of t-cell activation |
| 01/03/2013 | CA2836855A1 Polypeptides and uses thereof for treatment of autoimmune disorders and infection |
| 01/03/2013 | CA2835242A1 Anti-c-met antibody formulations |
| 01/02/2013 | EP2541252A1 Method of obtaining a binder to prepro-vasopressin or fragments thereof |
| 01/02/2013 | EP2540827A1 Anti-icam3 antibody and use thereof |
| 01/02/2013 | EP2540820A1 Means and methods for influencing the stability of antibody producing cells |
| 01/02/2013 | EP2540745A1 Fully humanized anti-her2 antibody, preparation method and use thereof |
| 01/02/2013 | EP2540744A1 Fully human monoclonal antibody to vegf, preparation method and use thereof |
| 01/02/2013 | EP2540743A1 Full human anti-tnf- alpha monoclonal antibody, preparation method and use thereof |
| 01/02/2013 | EP2540741A1 Humanized anti-CD22 antibodies and their use in treatment of oncology, transplantation and autoimmune disease |
| 01/02/2013 | EP2539370A2 Anti-alpha2 integrin antibodies and their uses |
| 01/02/2013 | EP2539369A1 Antagonist anti-il-7 receptor antibodies and methods |
| 01/02/2013 | EP2539368A1 Cancer vaccine |
| 01/02/2013 | EP2539367A2 Anti-angiogenesis therapy for the treatment of ovarian cancer |